Americans Are Happier with This Car Brand Than Any Other
Americans may love their cars, but these days they love them a little less.
Consumer satisfaction with their cars has fallen for the third consecutive year, reflecting unhappiness with increasing recalls and rising prices, according to new data from the American Customer Satisfaction Index.
Car reliability has improved overall in the past decade but the number of recalls is at an all-time high. “This should not happen with modern manufacturing technology and has negative consequences for driver safety, costs, and customer satisfaction,” ACSI Chairman and founder Claes Fornell said in a statement.
Car owners in the second quarter of 2015 reported a 40 percent increase in recalls year over year. The most high profile recalls involve Takata airbags, affecting more than 17 million older-model vehicles built by 11 different auto makers.
Related: Senators Urge Recall of All Vehicles with Takata Airbags
Looking at individual brands, the index shows that Americans prefer Japanese and luxury brand cars, with Lexus displacing Mercedes Benz as the brand with the highest overall satisfaction (84 out of 100). Mercedes tied for second place with Acura and Lincoln.
The average for all autos fell 3.7 points to 79. The only American automaker to rank above average was Ford with a score of 81. General Motors and Chrysler saw their scores fall modestly to 79 and 75 respectively.
Despite a growing decline in satisfaction, Americans are holding onto their vehicles longer than ever. The average age of cars and light trucks is now 11.5 years old, according to a report issued last month by IHS Automotive.
Top Reads from the Fiscal Times:
- Big Surprise: Hispanic Voters Can’t Stand Donald Trump
- How a Biden-Warren Ticket Could Transform the Campaign
- Air Force Brushes Off $27 Billion Accounting Error
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
